JP2007518760A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007518760A5 JP2007518760A5 JP2006549999A JP2006549999A JP2007518760A5 JP 2007518760 A5 JP2007518760 A5 JP 2007518760A5 JP 2006549999 A JP2006549999 A JP 2006549999A JP 2006549999 A JP2006549999 A JP 2006549999A JP 2007518760 A5 JP2007518760 A5 JP 2007518760A5
- Authority
- JP
- Japan
- Prior art keywords
- dry weight
- weight basis
- pharmaceutically acceptable
- tablet
- dpp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53770604P | 2004-01-20 | 2004-01-20 | |
| US60/537,706 | 2004-01-20 | ||
| US60427404P | 2004-08-25 | 2004-08-25 | |
| US60/604,274 | 2004-08-25 | ||
| PCT/EP2005/000400 WO2005067976A2 (en) | 2004-01-20 | 2005-01-17 | Direct compression formulation and process |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012107450A Division JP5739835B2 (ja) | 2004-01-20 | 2012-05-09 | 直接圧縮製剤および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007518760A JP2007518760A (ja) | 2007-07-12 |
| JP2007518760A5 true JP2007518760A5 (https=) | 2008-03-06 |
| JP5122144B2 JP5122144B2 (ja) | 2013-01-16 |
Family
ID=34798877
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006549999A Expired - Lifetime JP5122144B2 (ja) | 2004-01-20 | 2005-01-17 | 直接圧縮製剤および方法 |
| JP2012107450A Expired - Lifetime JP5739835B2 (ja) | 2004-01-20 | 2012-05-09 | 直接圧縮製剤および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012107450A Expired - Lifetime JP5739835B2 (ja) | 2004-01-20 | 2012-05-09 | 直接圧縮製剤および方法 |
Country Status (31)
| Country | Link |
|---|---|
| US (4) | US20080038341A1 (https=) |
| EP (5) | EP2165703A3 (https=) |
| JP (2) | JP5122144B2 (https=) |
| KR (1) | KR101259645B1 (https=) |
| AR (1) | AR049000A1 (https=) |
| AU (1) | AU2005205055B2 (https=) |
| BR (3) | BR122018014389B1 (https=) |
| CA (1) | CA2552569C (https=) |
| CY (3) | CY1110522T1 (https=) |
| DE (1) | DE602005015421D1 (https=) |
| DK (3) | DK3366283T3 (https=) |
| EC (3) | ECSP066707A (https=) |
| ES (4) | ES2899417T3 (https=) |
| HR (2) | HRP20211766T1 (https=) |
| HU (2) | HUE039902T2 (https=) |
| IL (1) | IL176831A0 (https=) |
| LT (2) | LT3023095T (https=) |
| MA (1) | MA28305A1 (https=) |
| MX (1) | MXPA06008265A (https=) |
| MY (1) | MY138450A (https=) |
| NO (2) | NO345116B1 (https=) |
| NZ (2) | NZ578743A (https=) |
| PE (1) | PE20050686A1 (https=) |
| PH (1) | PH12019501331A1 (https=) |
| PL (4) | PL3738585T3 (https=) |
| PT (4) | PT3023095T (https=) |
| RS (2) | RS57561B1 (https=) |
| RU (1) | RU2766487C2 (https=) |
| SI (3) | SI1715893T1 (https=) |
| TW (1) | TWI374760B (https=) |
| WO (1) | WO2005067976A2 (https=) |
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2766487C2 (ru) | 2004-01-20 | 2022-03-15 | Новартис Аг | Композиция и способ прямого прессования |
| AU2005210285B2 (en) | 2004-02-05 | 2008-01-24 | Kyorin Pharmaceutical Co., Ltd. | Bicycloester derivative |
| JP5025468B2 (ja) * | 2004-06-17 | 2012-09-12 | メルツ・ファルマ・ゲゼルシヤフト・ミト・ベシュレンクテル・ハフツング・ウント・コンパニー・コマンデイトゲゼルシヤフト・アウフ・アクティーン | メマンチン又はネラメキサンの直接圧縮によって製造された、飲用に適した即効型錠剤 |
| GT200600008A (es) * | 2005-01-18 | 2006-08-09 | Formulacion de compresion directa y proceso | |
| JP2008024592A (ja) * | 2005-01-28 | 2008-02-07 | Taisho Pharmaceut Co Ltd | シアノピロリジン誘導体含有固形製剤用組成物、それを含有する固形製剤及びその製造方法 |
| KR20080000665A (ko) | 2005-04-22 | 2008-01-02 | 알란토스 파마슈티컬즈 홀딩, 인코포레이티드 | 디펩티딜 펩티다아제-ⅳ 억제제 |
| CA2617715A1 (en) * | 2005-08-11 | 2007-02-15 | F. Hoffmann-La Roche Ag | Pharmaceutical composition comprising a dpp-iv inhibitor |
| BRPI0616694B8 (pt) * | 2005-09-29 | 2021-05-25 | Novartis Ag | processo para preparar comprimido farmacêutico com 80 e 96% em peso com base no peso seco de vildagliptina e metformina ou seus sais farmaceuticamente aceitáveis |
| PT1976522E (pt) | 2005-12-30 | 2013-09-09 | Krka Tovarna Zdravil D D Novo Mesto | Composição farmacêutica contendo montelucaste |
| DE602006004694D1 (de) * | 2006-01-05 | 2009-02-26 | Teva Pharma | Feuchtgranulierungsmethode zur Herstellung pharmazeutischer Aripiprazolzusammensetzungen |
| EP1995237A4 (en) | 2006-03-08 | 2011-07-06 | Kyorin Seiyaku Kk | PROCESS FOR PREPARING AN AMINOACETYLPYRROLIDINCARBONITRILE DERIVATIVE AND PRODUCTION PRODUCT THEREOF |
| TWI453041B (zh) | 2007-02-01 | 2014-09-21 | Takeda Pharmaceutical | 固體型製劑 |
| AR065096A1 (es) * | 2007-02-01 | 2009-05-13 | Takeda Pharmaceutical | Preparacion solida |
| US20100016322A1 (en) * | 2007-02-28 | 2010-01-21 | Nagesh Nagaraju | Water Dispersible Pharmaceutical Formulation and Process for Preparing The Same |
| JP5432720B2 (ja) | 2007-03-13 | 2014-03-05 | 武田薬品工業株式会社 | ２−［［６−［（３ｒ）−３−アミノ−１−ピペリジニル］−３，４−ジヒドロ−３−メチル−２，４−ジオキソ−１（２ｈ）−ピリミジニル］メチル］−４−フルオロベンゾニトリルを含む固形製剤 |
| WO2008114857A1 (ja) | 2007-03-22 | 2008-09-25 | Kyorin Pharmaceutical Co., Ltd. | アミノアセチルピロリジンカルボニトリル誘導体の製造方法 |
| CL2008002427A1 (es) | 2007-08-16 | 2009-09-11 | Boehringer Ingelheim Int | Composicion farmaceutica que comprende 1-cloro-4-(b-d-glucopiranos-1-il)-2-[4-((s)-tetrahidrofurano-3-iloxi)bencil]-benceno combinado con 1-[(4-metilquinazolin-2-il)metil]-3-metil-7-(2-butin-1-il)-8-(3-(r)-aminopiperidin-1-il)xantina; y su uso para tratar diabetes mellitus tipo 2. |
| UY32030A (es) | 2008-08-06 | 2010-03-26 | Boehringer Ingelheim Int | "tratamiento para diabetes en pacientes inapropiados para terapia con metformina" |
| WO2010016584A1 (ja) * | 2008-08-07 | 2010-02-11 | 杏林製薬株式会社 | ビシクロ[２．２．２]オクチルアミン誘導体の製造方法 |
| KR20110044780A (ko) * | 2008-08-14 | 2011-04-29 | 교린 세이야꾸 가부시키 가이샤 | 안정화된 의약 조성물 |
| NZ604091A (en) | 2008-08-15 | 2014-08-29 | Boehringer Ingelheim Int | Purin derivatives for use in the treatment of fab-related diseases |
| AR074990A1 (es) | 2009-01-07 | 2011-03-02 | Boehringer Ingelheim Int | Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina |
| AR075204A1 (es) | 2009-01-29 | 2011-03-16 | Boehringer Ingelheim Int | Inhibidores de dpp-4 y composiciones farmaceuticas que los comprenden, utiles para tratar enfermedades metabolicas en pacientes pediatricos, particularmente diabetes mellitus tipo 2 |
| UY32427A (es) | 2009-02-13 | 2010-09-30 | Boheringer Ingelheim Internat Gmbh | Composicion farmaceutica, forma farmaceutica, procedimiento para su preparacion, metodos de tratamiento y usos de la misma |
| DK2396005T3 (da) | 2009-02-13 | 2026-02-09 | Boehringer Ingelheim Int | Sglt2 hæmmer til at forbedre glykæmisk kontrol |
| AU2010212823B2 (en) | 2009-02-13 | 2016-01-28 | Boehringer Ingelheim International Gmbh | Antidiabetic medications comprising a DPP-4 inhibitor (linagliptin) optionally in combination with other antidiabetics |
| JP5685550B2 (ja) | 2009-02-13 | 2015-03-18 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｓｇｌｔ２阻害剤、ｄｐｐ−ｉｖ阻害剤、更に必要により抗糖尿病薬を含む医薬組成物及びその使用 |
| CN102438617A (zh) | 2009-03-27 | 2012-05-02 | 杏林制药株式会社 | 含有碱性添加剂的基质型缓释制剂 |
| UY32919A (es) | 2009-10-02 | 2011-04-29 | Boehringer Ingelheim Int | Composición farmacéutica, forma de dosificación farmacéutica, procedimiento para su preparación, mé todos para su tratamiento y sus usos |
| KR20240090632A (ko) | 2009-11-27 | 2024-06-21 | 베링거 인겔하임 인터내셔날 게엠베하 | 리나글립틴과 같은 ｄｐｐ－ｉｖ 억제제를 사용한 유전자형 검사된 당뇨병 환자의 치료 |
| US9572806B2 (en) * | 2009-12-18 | 2017-02-21 | Mitsubishi Tanabe Pharma Corporation | Elution-stabilized preparation |
| EP2633857B1 (en) | 2009-12-23 | 2015-08-12 | ratiopharm GmbH | Solid pharmaceutical dosage form of ticagrelor and acetylsalicylic acid |
| EP2547339A1 (en) | 2010-03-18 | 2013-01-23 | Boehringer Ingelheim International GmbH | Combination of a gpr119 agonist and the dpp-iv inhibitor linagliptin for use in the treatment of diabetes and related conditions |
| CN102946875A (zh) | 2010-05-05 | 2013-02-27 | 贝林格尔.英格海姆国际有限公司 | 组合疗法 |
| WO2011161161A1 (en) | 2010-06-24 | 2011-12-29 | Boehringer Ingelheim International Gmbh | Diabetes therapy |
| AR085689A1 (es) | 2011-03-07 | 2013-10-23 | Boehringer Ingelheim Int | Composiciones farmaceuticas de metformina, linagliptina y un inhibidor de sglt-2 |
| ES2421956B1 (es) | 2012-03-02 | 2014-09-29 | Moehs Ibérica S.L. | Nueva forma cristalina de sulfato de sitagliptina |
| WO2013174767A1 (en) | 2012-05-24 | 2013-11-28 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference |
| AR092843A1 (es) | 2012-06-05 | 2015-05-06 | Takeda Pharmaceuticals Co | Preparacion solida |
| JP6283316B2 (ja) * | 2012-10-26 | 2018-02-21 | 株式会社三和化学研究所 | アナグリプチン含有固形製剤 |
| EP2769712A1 (en) | 2013-02-21 | 2014-08-27 | Siegfried International AG | Pharmaceutical formulation comprising DPP-IV inhibitor agglomerates and DPP-IV inhibitor particles |
| CA2812519A1 (en) | 2013-04-05 | 2014-10-05 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
| US11813275B2 (en) | 2013-04-05 | 2023-11-14 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
| HK1213818A1 (zh) | 2013-04-05 | 2016-07-15 | 勃林格殷格翰国际有限公司 | 依帕列净的治疗用途 |
| TR201901110T4 (tr) | 2013-04-05 | 2019-02-21 | Boehringer Ingelheim Int | Empagliflozinin terapötik kullanımları. |
| EP4678242A3 (en) | 2013-04-18 | 2026-03-18 | Boehringer Ingelheim International GmbH | Pharmaceutical composition, methods for treating and uses thereof |
| EP2915528A1 (en) | 2014-03-06 | 2015-09-09 | Sanovel Ilac Sanayi ve Ticaret A.S. | Vildagliptin formulation process under inert gas atmosphere |
| TR201402685A1 (tr) | 2014-03-06 | 2015-09-21 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Vildagliptinin farmasotik formulasyonları. |
| PL3512505T3 (pl) | 2016-09-16 | 2023-08-07 | Galenicum Health S.L.U. | Farmaceutyczne kompozycje wildagliptyny |
| KR20190084096A (ko) | 2016-11-10 | 2019-07-15 | 베링거 인겔하임 인터내셔날 게엠베하 | 약제학적 조성물, 치료 방법 및 이의 용도 |
| GR1009406B (el) | 2017-10-03 | 2018-11-26 | Φαρματεν Αβεε | Φαρμακευτικο σκευασμα που περιλαμβανει βιλνταγλιπτινη και μεθοδος για την παρασκευη αυτου |
| KR102622198B1 (ko) | 2018-03-30 | 2024-01-09 | 한미약품 주식회사 | 빌다글립틴을 함유하는 경구용 고형제제 및 그의 제조 방법 |
| GR1009644B (el) | 2018-09-25 | 2019-11-12 | Φαρματεν Α.Β.Ε.Ε. | Φαρμακευτικο σκευασμα που περιλαμβανει βιλνταγλιπτινη και μετφορμινη και μεθοδος για την παρασκευη αυτου |
| BE1026818B1 (fr) * | 2018-11-30 | 2020-06-30 | Hedelab Sa | Procede de fabrication d'une serie de n preparations pour complements alimentaires |
| KR102693304B1 (ko) | 2019-04-16 | 2024-08-08 | 한미약품 주식회사 | 빌다글립틴 염산염 함유 복합 제제의 안정성 개선을 위한 포장재 |
| JP7461735B2 (ja) * | 2019-12-02 | 2024-04-04 | 日本ジェネリック株式会社 | ビルダグリプチン含有錠剤 |
| CN113018270A (zh) * | 2019-12-24 | 2021-06-25 | 四川科瑞德制药股份有限公司 | 一种高稳定的盐酸米那普仑制剂及其制备方法 |
| US20260048019A1 (en) * | 2022-08-12 | 2026-02-19 | Hoffmann-La Roche Inc. | Use of co-processed excipients in continuous manufacturing of solid dosage forms |
Family Cites Families (88)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3131402A1 (de) * | 1981-08-07 | 1983-02-24 | Kilian & Co GmbH, 5000 Köln | Verfahren und tablettenpresse zum aufeinanderfolgenden herstellen einer vielzahl von tabletten mit gleichem gewicht |
| US4894236A (en) * | 1988-01-12 | 1990-01-16 | Choong-Gook Jang | Direct compression tablet binders for acetaminophen |
| DE3833448A1 (de) * | 1988-10-01 | 1990-04-12 | Hoechst Ag | Verfahren zur gewinnung von ibuprofen fuer die direkttablettierung |
| MX9206628A (es) | 1991-11-22 | 1993-05-01 | Boehringer Ingelheim Pharma | Ester de prolinaboronato y metodo para su preparacion. |
| JP3784084B2 (ja) * | 1993-10-21 | 2006-06-07 | 武田薬品工業株式会社 | 医薬用錠剤 |
| IL111785A0 (en) | 1993-12-03 | 1995-01-24 | Ferring Bv | Dp-iv inhibitors and pharmaceutical compositions containing them |
| JP3534130B2 (ja) * | 1994-03-01 | 2004-06-07 | 旭化成ケミカルズ株式会社 | 医薬品組成物 |
| US5543396A (en) | 1994-04-28 | 1996-08-06 | Georgia Tech Research Corp. | Proline phosphonate derivatives |
| DE122010000020I1 (de) | 1996-04-25 | 2010-07-08 | Prosidion Ltd | Verfahren zur Senkung des Blutglukosespiegels in Säugern |
| WO1998018763A1 (en) | 1996-10-25 | 1998-05-07 | Tanabe Seiyaku Co., Ltd. | Tetrahydroisoquinoline derivatives |
| TW492957B (en) | 1996-11-07 | 2002-07-01 | Novartis Ag | N-substituted 2-cyanopyrrolidnes |
| US6011155A (en) | 1996-11-07 | 2000-01-04 | Novartis Ag | N-(substituted glycyl)-2-cyanopyrrolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV |
| DE69839279T2 (de) | 1997-11-18 | 2009-05-28 | Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai | Neue physiologisch aktive substanz sulphostin, herstellung und verwendung derselben |
| EP2583675A1 (en) | 1998-02-02 | 2013-04-24 | Trustees Of Tufts College | Use of dipeptidylpeptidase inhibitors to regulate glucose metabolism |
| JP2002506075A (ja) | 1998-03-09 | 2002-02-26 | フォンダテッヒ・ベネルクス・ナムローゼ・フェンノートシャップ | セリンペプチダーゼ調節剤 |
| DE19823831A1 (de) * | 1998-05-28 | 1999-12-02 | Probiodrug Ges Fuer Arzneim | Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen |
| DE19828113A1 (de) | 1998-06-24 | 2000-01-05 | Probiodrug Ges Fuer Arzneim | Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV |
| DE19828114A1 (de) | 1998-06-24 | 2000-01-27 | Probiodrug Ges Fuer Arzneim | Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV |
| KR100676389B1 (ko) | 1998-07-10 | 2007-01-30 | 닛폰 하츠죠 가부시키가이샤 | 도전성 접촉자 |
| US6088938A (en) | 1998-07-17 | 2000-07-18 | Logan; John Duncan | Implement adapter for an excavation tool assembly |
| CO5150173A1 (es) * | 1998-12-10 | 2002-04-29 | Novartis Ag | Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv |
| US6110949A (en) | 1999-06-24 | 2000-08-29 | Novartis Ag | N-(substituted glycyl)-4-cyanothiazolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV |
| US6107317A (en) | 1999-06-24 | 2000-08-22 | Novartis Ag | N-(substituted glycyl)-thiazolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV |
| US6414002B1 (en) | 1999-09-22 | 2002-07-02 | Bristol-Myers Squibb Company | Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| JP2003535034A (ja) | 1999-11-12 | 2003-11-25 | ギルフォード ファーマシューティカルズ インコーポレイテッド | ジペプチジルペプチダーゼｉｖ阻害剤並びにジペプチジルペプチダーゼｉｖ阻害剤の製造及び使用法 |
| GB9928330D0 (en) | 1999-11-30 | 2000-01-26 | Ferring Bv | Novel antidiabetic agents |
| HUP0203865A3 (en) * | 1999-11-30 | 2004-05-28 | Dainippon Pharmaceutical Co | Solid pharmaceutical composition containing crystal of [3-[(2r)-[[(2r)-(3-clorophenyl)-2-hydroxy-ethyl]amino]propyl]-1h-indol-7-yloxy]-acetic acid |
| EP1743655B1 (en) | 2000-01-21 | 2014-06-25 | Novartis AG | Combinations comprising dipeptidylpeptidase-iv inhibitors and antidiabetic agents |
| WO2001055105A1 (en) | 2000-01-24 | 2001-08-02 | Novo Nordisk A/S | N-substituted 2-cyanopyroles and -pyrrolines which are inhibitors of the enzyme dpp-iv |
| US6395767B2 (en) | 2000-03-10 | 2002-05-28 | Bristol-Myers Squibb Company | Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
| KR20080067009A (ko) | 2000-03-31 | 2008-07-17 | 프로시디온 리미티드 | 디펩티딜 펩티다제 ⅳ 효소 활성 억제제를 포함하는약제학적 조성물 |
| US6482844B1 (en) | 2000-04-07 | 2002-11-19 | Neurogen Corporation | 1-benzylimidazole derivatives |
| GB0010188D0 (en) | 2000-04-26 | 2000-06-14 | Ferring Bv | Inhibitors of dipeptidyl peptidase IV |
| GB0010183D0 (en) | 2000-04-26 | 2000-06-14 | Ferring Bv | Inhibitors of dipeptidyl peptidase IV |
| GB0014969D0 (en) | 2000-06-19 | 2000-08-09 | Smithkline Beecham Plc | Novel method of treatment |
| AU2001268958B2 (en) | 2000-07-04 | 2006-03-09 | Novo Nordisk A/S | Heterocyclic compounds, which are inhibitors of the enzyme dpp-iv |
| JP4101053B2 (ja) | 2000-08-10 | 2008-06-11 | 田辺三菱製薬株式会社 | プロリン誘導体及びその医薬用途 |
| BR0114436A (pt) | 2000-10-06 | 2003-07-01 | Tanabe Seiyaku Co | Composto com anel de cinco elementos contendo nitrogênio alifático |
| WO2002030400A1 (fr) * | 2000-10-06 | 2002-04-18 | Takeda Chemical Industries, Ltd. | Preparations solides |
| TWI243162B (en) | 2000-11-10 | 2005-11-11 | Taisho Pharmaceutical Co Ltd | Cyanopyrrolidine derivatives |
| CA2433090A1 (en) | 2000-12-27 | 2002-07-04 | Kyowa Hakko Kogyo Co., Ltd. | Dipeptidyl peptidase iv inhibitor |
| WO2002053548A1 (fr) | 2000-12-27 | 2002-07-11 | Banyu Pharmaceutical Co.,Ltd. | Derives de la benzothiazepine |
| SK10802003A3 (sk) | 2001-02-02 | 2004-05-04 | Takeda Chemical Industries, Ltd. | Kondenzovaná heterocyklická zlúčenina, jej použitie a jej farmaceutický prípravok |
| WO2002066627A1 (en) | 2001-02-16 | 2002-08-29 | Bayer Aktiengesellschaft | Regulation of human dipeptidyl peptidase 8 |
| EP1368349B1 (de) | 2001-02-24 | 2007-02-14 | Boehringer Ingelheim Pharma GmbH & Co.KG | Xanthinderivate, deren herstellung und deren verwendung als arzneimittel |
| WO2002067918A1 (en) | 2001-02-27 | 2002-09-06 | Banyu Pharmaceutical Co., Ltd. | Novel diallylmethylamine derivative |
| EP1385508B1 (en) | 2001-03-27 | 2008-05-21 | Merck & Co., Inc. | Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| FR2822826B1 (fr) | 2001-03-28 | 2003-05-09 | Servier Lab | Nouveaux derives sulfonyles d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| GB0109146D0 (en) | 2001-04-11 | 2001-05-30 | Ferring Bv | Treatment of type 2 diabetes |
| US6573287B2 (en) | 2001-04-12 | 2003-06-03 | Bristo-Myers Squibb Company | 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase IV and method |
| MXPA03009847A (es) | 2001-04-27 | 2004-02-12 | Vertex Pharma | Inhibidores de cinasa derivados de pirazol. |
| FR2824825B1 (fr) * | 2001-05-15 | 2005-05-06 | Servier Lab | Nouveaux derives d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| SE523510C2 (sv) | 2001-05-18 | 2004-04-27 | Jan G Faeger | Förfarande för att fastställa en varelses position och/eller orientering i förhållande till en omgivning |
| US20030060494A1 (en) | 2001-05-18 | 2003-03-27 | Nobuyuki Yasuda | Pharmaceutical use of N-carbamoylazole derivatives |
| ES2257555T3 (es) | 2001-06-20 | 2006-08-01 | MERCK & CO., INC. | Inhibidores de dipeptidilpeptidasa para el tratamiento de la diabetes. |
| CA2450579A1 (en) | 2001-06-20 | 2003-01-03 | Merck & Co., Inc. | Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| GB0115517D0 (en) | 2001-06-25 | 2001-08-15 | Ferring Bv | Novel antidiabetic agents |
| CN1723196A (zh) | 2001-06-27 | 2006-01-18 | 史密丝克莱恩比彻姆公司 | 作为二肽酶抑制剂的氟代吡咯烷 |
| JP4357293B2 (ja) | 2001-06-27 | 2009-11-04 | スミスクライン ビーチャム コーポレーション | ジペプチジルペプチダーゼ阻害剤としてのフルオロピロリジン類 |
| RU2003105463A (ru) | 2001-06-27 | 2004-11-27 | Пробиодруг Аг (De) | Пептидные структуры, пригодные для конкурентного модулирования катализа, осуществляемого дипептидилпептидазой iv |
| US20030005443A1 (en) | 2001-06-27 | 2003-01-02 | Karin Axelsson | EPG having PIP window history and sample view functionality |
| WO2003003250A1 (en) | 2001-06-28 | 2003-01-09 | Hywire Ltd. | Range content-addressable memory |
| DE60225556D1 (de) | 2001-07-03 | 2008-04-24 | Novo Nordisk As | Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes |
| UA74912C2 (en) | 2001-07-06 | 2006-02-15 | Merck & Co Inc | Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes |
| KR20040033048A (ko) | 2001-09-14 | 2004-04-17 | 미츠비시 웰파마 가부시키가이샤 | 티아졸리딘 유도체 및 이의 약학적 용도 |
| AU2002331311A1 (en) | 2001-09-19 | 2003-04-01 | Novo Nordisk A/S | Heterocyclic compounds that are inhibitors of the enzyme dpp-iv |
| SE0103424D0 (sv) | 2001-10-15 | 2001-10-15 | Astrazeneca Ab | Pharmaceutical formulation |
| GB0125445D0 (en) | 2001-10-23 | 2001-12-12 | Ferring Bv | Protease Inhibitors |
| GB0125446D0 (en) | 2001-10-23 | 2001-12-12 | Ferring Bv | Novel anti-diabetic agents |
| US6861440B2 (en) | 2001-10-26 | 2005-03-01 | Hoffmann-La Roche Inc. | DPP IV inhibitors |
| AU2003201274A1 (en) | 2002-01-11 | 2003-07-24 | Novo Nordisk A/S | Compositions comprising inhibitors of dpp-iv and nep enzymes for the treatment of diabetes |
| EP1465605A1 (en) * | 2002-01-11 | 2004-10-13 | Athpharma Limited | Pravastatin pharmaceutical formulations and methods of their use |
| JP4359146B2 (ja) | 2002-02-13 | 2009-11-04 | エフ．ホフマン−ラ ロシュ アーゲー | 新規なピリジン−およびピリミジン−誘導体 |
| HUP0200849A2 (hu) | 2002-03-06 | 2004-08-30 | Sanofi-Synthelabo | N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra |
| WO2003084940A1 (en) | 2002-04-08 | 2003-10-16 | Alangudi Sankaranarayanan | Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors |
| JP2003327532A (ja) * | 2002-05-10 | 2003-11-19 | Takeda Chem Ind Ltd | ペプチダーゼ阻害剤 |
| ATE422884T1 (de) | 2002-06-03 | 2009-03-15 | Novartis Pharma Gmbh | Verwendung von substituierten cyanopyrrolidinen zur behandlung von hyperlipidämie |
| AU2003262059A1 (en) * | 2002-09-11 | 2004-04-30 | Takeda Pharmaceutical Company Limited | Sustained release preparation |
| CA2502269C (en) | 2002-10-18 | 2009-12-22 | Merck & Co., Inc. | Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| ATE469645T1 (de) | 2002-10-23 | 2010-06-15 | Bristol Myers Squibb Co | Auf glycinnitril basierende hemmer der dipeptidylpeptidase iv |
| DE10256264A1 (de) | 2002-12-03 | 2004-06-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Imidazo-pyridinone und Imidazo-pyridazinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
| US7420079B2 (en) | 2002-12-09 | 2008-09-02 | Bristol-Myers Squibb Company | Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof |
| WO2004071454A2 (en) | 2003-02-13 | 2004-08-26 | Guilford Pharmaceuticals Inc. | Substituted azetidine compounds as inhibitors of dipeptidyl peptidase iv |
| WO2004076433A1 (en) | 2003-02-28 | 2004-09-10 | Aic | Dipeptidyl peptidase inhibitors |
| US20040186046A1 (en) * | 2003-03-17 | 2004-09-23 | Pfizer Inc | Treatment of type 1 diabetes with PDE5 inhibitors |
| PE20050021A1 (es) | 2003-04-16 | 2005-03-15 | Novartis Ag | Procedimiento para la preparacion de 2-cianopirrolidina n-sustituida |
| RU2766487C2 (ru) | 2004-01-20 | 2022-03-15 | Новартис Аг | Композиция и способ прямого прессования |
| AR050615A1 (es) | 2004-08-27 | 2006-11-08 | Novartis Ag | Composiciones farmaceuticas para la administracion oral |
-
2005
- 2005-01-17 RU RU2006130009A patent/RU2766487C2/ru active
- 2005-01-17 PT PT15199440T patent/PT3023095T/pt unknown
- 2005-01-17 RS RS20180946A patent/RS57561B1/sr unknown
- 2005-01-17 KR KR1020067014506A patent/KR101259645B1/ko not_active Expired - Fee Related
- 2005-01-17 EP EP20090157626 patent/EP2165703A3/en not_active Withdrawn
- 2005-01-17 PT PT181655457T patent/PT3366283T/pt unknown
- 2005-01-17 ES ES18165545T patent/ES2899417T3/es not_active Expired - Lifetime
- 2005-01-17 PT PT201775061T patent/PT3738585T/pt unknown
- 2005-01-17 ES ES15199440T patent/ES2684325T5/es not_active Expired - Lifetime
- 2005-01-17 EP EP20177506.1A patent/EP3738585B1/en not_active Revoked
- 2005-01-17 WO PCT/EP2005/000400 patent/WO2005067976A2/en not_active Ceased
- 2005-01-17 PT PT05700976T patent/PT1715893E/pt unknown
- 2005-01-17 PL PL20177506.1T patent/PL3738585T3/pl unknown
- 2005-01-17 CA CA2552569A patent/CA2552569C/en not_active Expired - Lifetime
- 2005-01-17 DK DK18165545.7T patent/DK3366283T3/da active
- 2005-01-17 AU AU2005205055A patent/AU2005205055B2/en not_active Ceased
- 2005-01-17 SI SI200530794T patent/SI1715893T1/sl unknown
- 2005-01-17 BR BR122018014389-4A patent/BR122018014389B1/pt active IP Right Grant
- 2005-01-17 LT LTEP15199440.7T patent/LT3023095T/lt unknown
- 2005-01-17 HR HRP20211766TT patent/HRP20211766T1/hr unknown
- 2005-01-17 PL PL05700976T patent/PL1715893T3/pl unknown
- 2005-01-17 PL PL18165545T patent/PL3366283T3/pl unknown
- 2005-01-17 US US10/586,059 patent/US20080038341A1/en not_active Abandoned
- 2005-01-17 NZ NZ578743A patent/NZ578743A/en not_active IP Right Cessation
- 2005-01-17 EP EP05700976A patent/EP1715893B8/en not_active Revoked
- 2005-01-17 DK DK15199440.7T patent/DK3023095T3/en active
- 2005-01-17 MX MXPA06008265A patent/MXPA06008265A/es active IP Right Grant
- 2005-01-17 ES ES20177506T patent/ES2940341T3/es not_active Expired - Lifetime
- 2005-01-17 PL PL15199440T patent/PL3023095T3/pl unknown
- 2005-01-17 HU HUE15199440A patent/HUE039902T2/hu unknown
- 2005-01-17 ES ES05700976T patent/ES2332920T3/es not_active Expired - Lifetime
- 2005-01-17 EP EP18165545.7A patent/EP3366283B1/en not_active Expired - Lifetime
- 2005-01-17 LT LTEP18165545.7T patent/LT3366283T/lt unknown
- 2005-01-17 RS RS20211399A patent/RS62595B1/sr unknown
- 2005-01-17 DK DK05700976T patent/DK1715893T3/da active
- 2005-01-17 HU HUE18165545A patent/HUE056586T2/hu unknown
- 2005-01-17 EP EP15199440.7A patent/EP3023095B2/en not_active Expired - Lifetime
- 2005-01-17 NZ NZ548351A patent/NZ548351A/xx not_active IP Right Cessation
- 2005-01-17 JP JP2006549999A patent/JP5122144B2/ja not_active Expired - Lifetime
- 2005-01-17 SI SI200532299T patent/SI3366283T1/sl unknown
- 2005-01-17 BR BR122018073405-1A patent/BR122018073405B1/pt active IP Right Grant
- 2005-01-17 SI SI200532218T patent/SI3023095T1/sl unknown
- 2005-01-17 BR BRPI0507007-4A patent/BRPI0507007A/pt not_active Application Discontinuation
- 2005-01-17 DE DE602005015421T patent/DE602005015421D1/de not_active Expired - Lifetime
- 2005-01-19 TW TW094101577A patent/TWI374760B/zh not_active IP Right Cessation
- 2005-01-19 AR ARP050100182A patent/AR049000A1/es not_active Application Discontinuation
- 2005-01-19 PE PE2005000075A patent/PE20050686A1/es not_active Application Discontinuation
- 2005-01-19 MY MYPI20050199A patent/MY138450A/en unknown
-
2006
- 2006-07-13 IL IL176831A patent/IL176831A0/en active IP Right Review Request
- 2006-07-18 EC EC2006006707A patent/ECSP066707A/es unknown
- 2006-07-24 MA MA29205A patent/MA28305A1/fr unknown
- 2006-08-21 NO NO20063739A patent/NO345116B1/no unknown
-
2009
- 2009-10-14 CY CY20091101062T patent/CY1110522T1/el unknown
-
2011
- 2011-06-06 US US13/154,063 patent/US20110236479A1/en not_active Abandoned
- 2011-08-04 EC EC2011006707A patent/ECSP11006707A/es unknown
-
2012
- 2012-05-09 JP JP2012107450A patent/JP5739835B2/ja not_active Expired - Lifetime
- 2012-07-31 US US13/562,415 patent/US20120294939A1/en not_active Abandoned
-
2014
- 2014-03-27 US US14/226,871 patent/US20140205663A1/en not_active Abandoned
-
2018
- 2018-08-03 HR HRP20181270TT patent/HRP20181270T1/hr unknown
- 2018-08-10 CY CY20181100840T patent/CY1120575T1/el unknown
- 2018-11-29 EC ECSENADI201889087A patent/ECSP18089087A/es unknown
-
2019
- 2019-06-13 PH PH12019501331A patent/PH12019501331A1/en unknown
-
2020
- 2020-08-10 NO NO20200892A patent/NO20200892A1/no unknown
-
2021
- 2021-11-29 CY CY20211101034T patent/CY1124770T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007518760A5 (https=) | ||
| CA2552569A1 (en) | Direct compression formulation and process | |
| RU2007131503A (ru) | Композиция для прямого прессования и способ | |
| KR100696350B1 (ko) | 급속 방출 정제 | |
| US20090186086A1 (en) | Solid multilayer oral dosage forms | |
| JP5622575B2 (ja) | 固形バルサルタン組成物 | |
| CA2501659A1 (en) | Deferasirox dispersible tablets | |
| SK284049B6 (sk) | Orálny prostriedok a spôsob jeho prípravy | |
| EA024699B1 (ru) | Фармацевтическая таблетка с немедленным высвобождением, содержащая севеламера карбонат | |
| CN101219120B (zh) | 替米沙坦分散片及其制备方法 | |
| TW202139977A (zh) | 包括阿托伐他汀以及怡妥錠的雙層片劑及其製造方法 | |
| US20120107397A1 (en) | Pharmaceutical compositions of valsartan | |
| WO2019219920A1 (en) | Stable pharmaceutical compositions of dpp-iv inhibitors in combination with metformin in the form of immediate release tablets | |
| WO2018211479A1 (en) | Stabilized compositions of angiotensin ii inhibitors and neutral endopeptidase inhibitors and process for preparation thereof | |
| WO2010120963A1 (en) | Tablet formulation for p38 inhibitor and method | |
| WO2010057449A2 (en) | A solid pharmaceutical composition with atorvastatin and telmisartan as the active substances | |
| WO2000071117A1 (en) | Immediate release medicinal compositions for oral use | |
| US20080008751A1 (en) | Stable formulation comprising a combination of a moisture sensitive drug and a second drug and manufacturing procedure thereof | |
| JP5113476B2 (ja) | 保存安定性に優れた塩酸テモカプリルの錠剤 | |
| RU2007147949A (ru) | Композиция, содержащая ингибиторы dpp-iv глитазоны, полученная прямым прессованием, и способ ее получения | |
| JP2007161706A (ja) | 安中散含有錠剤 | |
| CN102028670A (zh) | 一种包含替米沙坦和钙离子通道拮抗剂的复方胶囊剂 | |
| JP7437039B2 (ja) | 錠剤 | |
| US20030229101A1 (en) | Tablets comprising ciprofloxacin hydrochloride | |
| CA2659814A1 (en) | Stable formulation comprising a combination of a moisture sensitive drug and a second drug and manufacturing procedure thereof |